The ultimate target in the pharmaceutical and medical device industries is to ensure patient safety within the entire product lifecycle, from R&D to distribution. The …
This article by Susan Najjar from Sciformix, a Covance Company, discusses the complexity organisations face when developing a business strategy around “The Patient Journey” and …
Dr Paul Peter Tak of GlaxoSmithKline describes the possible, disadvantageous consequences of a no-deal Brexit.
In recent years, the term “patient-centric” has become more commonplace in the world of clinical and medical research, indicating greater interest in putting the patient …
In recent years, the term “patient-centric” has become more commonplace in the world of clinical and medical research, indicating greater interest in putting the patient …
In Turkey, the active population, retirees and their dependents are covered by health insurance provided by the Social Security Institution (SSI). The increase in the …
Modern patients have an interest in and expectation of playing a part in their own health matters, enabled by new digital connections and advanced technology. …
Pharmaceutical innovation has accelerated, but the way of dosing oral medicines to patients has broadly stayed the same. Martin Olovsson at OnDosis discusses the advantages …
The global pharmaceutical industry has entered an exciting new era of drug development, bringing new hope to patients around the world. Justin Schroeder at PCI …
Patch pump therapy is a convenient way of drug administration. The devices can be worn directly on the body as no tubing has to be …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
